The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 276, Issue 1, Pages 26-39
Publisher
Wiley
Online
2017-03-04
DOI
10.1111/imr.12521
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma
- (2016) Lei Wu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status
- (2016) Haiying Cheng et al. CLINICAL CANCER RESEARCH
- B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients
- (2016) Y. Yao et al. CLINICAL CANCER RESEARCH
- Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer
- (2016) Kurt A. Schalper et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
- (2016) E. Picarda et al. CLINICAL CANCER RESEARCH
- Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies
- (2016) Murali Janakiram et al. Immunotherapy
- Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy
- (2016) Jenessa B Smith et al. MOLECULAR THERAPY
- Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma
- (2016) Bo Hong WORLD JOURNAL OF GASTROENTEROLOGY
- HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
- (2016) Pratistha Koirala et al. Scientific Reports
- B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
- (2015) R. G. Veenstra et al. BLOOD
- B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis
- (2015) R. D. Pawar et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2
- (2015) Y. Xiao et al. CLINICAL CANCER RESEARCH
- Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3
- (2015) Mahiuddin Ahmed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response
- (2015) Jung-Tsu Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
- (2015) Krzysztof M. Zak et al. STRUCTURE
- New immunotherapies targeting the PD-1 pathway
- (2015) Jordan M. Chinai et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells
- (2015) Wei Zhang et al. OncoTargets and Therapy
- B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer
- (2015) Yixiang Mao et al. Oncotarget
- B7-H4 Expression Is Associated with Tumor Progression and Prognosis in Patients with Osteosarcoma
- (2015) Qiang Dong et al. Biomed Research International
- Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer
- (2015) K. Kreymborg et al. Cancer Immunology Research
- B7-H1 and B7-H4 expression in colorectal carcinoma: Correlation with tumor FOXP3+ regulatory T-cell infiltration
- (2014) Li-wei Zhao et al. ACTA HISTOCHEMICA
- B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
- (2014) Vibeke A Ingebrigtsen et al. BMC CANCER
- Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
- (2014) J Kraan et al. BRITISH JOURNAL OF CANCER
- Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
- (2014) M. Janakiram et al. CLINICAL CANCER RESEARCH
- B7-H3 expression in breast cancer and upregulation of VEGF through gene silence
- (2014) Jing Sun et al. OncoTargets and Therapy
- The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer
- (2014) Yan Chen et al. OncoTargets and Therapy
- Structure and Cancer Immunotherapy of the B7 Family Member B7x
- (2014) Hyungjun Jeon et al. Cell Reports
- B7-H4 Expression is Associated with Cancer Progression and Predicts Patient Survival in Human Thyroid Cancer
- (2013) Jian Zhu et al. Asian Pacific Journal of Cancer Prevention
- Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor Responses
- (2013) D. Dangaj et al. CANCER RESEARCH
- B7-H4.Ig inhibits the development of Type 1 diabetes by regulating Th17 cells in NOD mice
- (2013) I-Fang Lee et al. CELLULAR IMMUNOLOGY
- Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder
- (2013) E. Xylinas et al. EJSO
- B7-H3-mediated tumor immunology: Friend or foe?
- (2013) Ling Wang et al. INTERNATIONAL JOURNAL OF CANCER
- B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms
- (2013) Joseph R. Podojil et al. JOURNAL OF AUTOIMMUNITY
- Host B7x Promotes Pulmonary Metastasis of Breast Cancer
- (2013) Y. M. Abadi et al. JOURNAL OF IMMUNOLOGY
- B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma
- (2013) Jinhua Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis
- (2013) Ling Wang et al. PLoS One
- HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
- (2013) R. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
- (2013) Vladimir Vigdorovich et al. STRUCTURE
- B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
- (2013) Xiao Qin et al. OncoTargets and Therapy
- B7-H5 costimulates human T cells via CD28H
- (2013) Yuwen Zhu et al. Nature Communications
- B7x and myeloid-derived suppressor cells in the tumor microenvironment
- (2013) Hyungjun Jeon et al. OncoImmunology
- B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
- (2012) Tai-Wei Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses
- (2012) Takuya Ueno et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response
- (2012) Cheng Chen et al. EXPERIMENTAL CELL RESEARCH
- Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC
- (2012) Martin F. Flajnik et al. IMMUNOGENETICS
- B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer
- (2012) Vibeke Anett Ingebrigtsen et al. INTERNATIONAL JOURNAL OF CANCER
- Genome-wide identification and evolutionary analysis of B7-H3
- (2012) Hairong Duan et al. International Journal of Data Mining and Bioinformatics
- B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
- (2012) J. S. Lee et al. JOURNAL OF IMMUNOLOGY
- Tissue-Expressed B7x Affects the Immune Response to and Outcome of Lethal Pulmonary Infection
- (2012) K. A. Hofmeyer et al. JOURNAL OF IMMUNOLOGY
- B7-H3 Participates in the Development of Experimental Pneumococcal Meningitis by Augmentation of the Inflammatory Response via a TLR2-Dependent Mechanism
- (2012) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis
- (2012) Nader Rahimi et al. MOLECULAR BIOLOGY OF THE CELL
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinoma
- (2011) Lu-jun Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness
- (2011) D. Lemke et al. CLINICAL CANCER RESEARCH
- Early Treatment of NOD Mice With B7-H4 Reduces the Incidence of Autoimmune Diabetes
- (2011) X. Wang et al. DIABETES
- Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
- (2011) Andreas Brunner et al. GYNECOLOGIC ONCOLOGY
- Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
- (2011) Joyce Wei et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3
- (2011) Thomas Schneider et al. Journal of Thoracic Oncology
- B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
- (2011) Hexing Yuan et al. JOURNAL OF UROLOGY
- B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
- (2011) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Origination of New Immunological Functions in the Costimulatory Molecule B7-H3: The Role of Exon Duplication in Evolution of the Immune System
- (2011) Jing Sun et al. PLoS One
- B7-H3 and Its Role in Antitumor Immunity
- (2010) Martin Loos et al. Clinical & Developmental Immunology
- The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
- (2010) Je-In Youn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- B7-H3 Augments the Inflammatory Response and Is Associated with Human Sepsis
- (2010) G. Zhang et al. JOURNAL OF IMMUNOLOGY
- Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
- (2010) Xingxing Zang et al. MODERN PATHOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer
- (2009) Martin Loos et al. BMC CANCER
- Clinical importance of B7-H3 expression in human pancreatic cancer
- (2009) I Yamato et al. BRITISH JOURNAL OF CANCER
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
- (2009) H. Xu et al. CANCER RESEARCH
- Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
- (2009) J. A. Emamaullee et al. DIABETES
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
- (2009) Kim Kramer et al. JOURNAL OF NEURO-ONCOLOGY
- Potential Role of Decoy B7-H4 in the Pathogenesis of Rheumatoid Arthritis: A Mouse Model Informed by Clinical Data
- (2009) Takeshi Azuma et al. PLOS MEDICINE
- Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
- (2008) R. H. Thompson et al. CANCER RESEARCH
- The contrasting role of B7-H3
- (2008) K. A. Hofmeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
- (2008) D. Y.-w. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2
- (2008) E. Lazar-Molnar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation